- The invention relates to a method, and to an associated apparatus, for treating a container (1) comprising a glass wall (2) defining a receiving cavity (3) for receiving a product, said glass wall (2) having an inner face (4) and an opposite outer face (5), said glass wall (2) being provided with a first coating t...
- The invention relates to an installation (1) for treating the inner face (6) of the wall (3) of a glass container (2), which wall (3) delimits a receiving cavity (4) and an opening (5) providing access to the cavity (4), the installation (1) comprising a source (12) of a treatment substance (13) and a means (15) f...
- The invention relates to a method for treating the wall of a glass container (1), which wall delimits a cavity (4) and an opening providing access to said cavity (4), the method comprising: - the dispensing of a treatment substance into the cavity, using a dispensing means (12) of which a dispensing orifice (13) i...
- The invention relates to a method for dealkalisation of the inside surface (5) of the wall (2) of a glass container (1), which wall (2) defines a cavity (3) and an opening (4) providing access to the cavity (3), the method comprising a step of providing a container made of borosilicate glass, wherein the inside su...
The invention relates to a method for dealkalizing the inner face (5) of the wall (2) of a glass container (1), which wall (2) delimits a cavity (3) and an opening (4) providing access to the cavity (3), the method comprising a step of supplying a glass container, the inner face of the wall of which is at a temperat...
The invention relates to a container (1) comprising a wall (2) made of glass delimiting a cavity (3) to accommodate a substance, particularly a pharmaceutical or diagnostic substance, the glass wall (2) having an internal face (4) situated facing the accommodating cavity (3), the container (1) being characterized in...
The invention relates to a container (1) comprising a glass wall (2) defining a receiving cavity (3) for receiving a substance, in particular for a pharmaceutical or diagnostic substance, the glass wall (2) having an inner face (4) located facing the receiving cavity (3), the container (1) being characterized in tha...
Documents
Optional Attachment-(3)-31032017
Optional Attachment-(2)-31032017
Optional Attachment-(1)-31032017
Optional attachment(s) - if any-31032017
Directors? report as per section 134(3)-31032017
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-31032017
Optional Attachment-(4)-31032017
Form AOC-4-31032017_signed
Form AOC-4 additional attachment-31032017_signed
List of share holders, debenture holders;-23032017
Form MGT-7-23032017_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-03032017
Directors report as per section 134(3)-03032017
Optional attachment(s) - if any-03032017
Optional Attachment-(1)-03032017
Optional Attachment-(2)-03032017
Optional Attachment-(3)-03032017
Optional Attachment-(4)-03032017
Form AOC-4 additional attachment-03032017_signed
Form AOC-4-03032017_signed
List of share holders, debenture holders;-27122016